Sana Biotechnology (SANA) Other financing activities (2020 - 2026)
Sana Biotechnology (SANA) posted Other financing activities of $59000.0 for Q1 2026, down 94.43% sequentially from $1.1 million in Q4 2025, and down 94.76% YoY from $1.1 million in Q1 2025.
Sana Biotechnology (SANA) Other financing activities (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Other financing activities for 7 years, with the latest figure at $59000.0 in Q1 2026.
- Quarterly Other financing activities fell 94.76% year-over-year to $59000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 77.68% YoY) and the FY2025 annual result came in at $2.7 million, down 75.68% from the prior year.
- Other financing activities eased to $59000.0 in Q1 2026 per SANA's latest filing, from $1.1 million in the prior quarter.
- Over five years, Other financing activities peaked at $4.9 million in Q1 2024 and troughed at $59000.0 in Q1 2026.
- A 5-year average of $1.3 million and a median of $1.1 million in 2025 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2022 and 2024: Other financing activities sank 99.9% in 2022, then jumped 1988.56% in 2024.
- Over 5 years, Other financing activities stood at $1.2 million in 2022, then soared by 44.17% to $1.7 million in 2023, then slumped by 59.05% to $699000.0 in 2024, then soared by 51.5% to $1.1 million in 2025, then sank by 94.43% to $59000.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $59000.0, $1.1 million, and $157000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sana Biotechnology | 1.06 Bn | 1.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 245,000.00 |
| Jun 30, 2026 | 245,000.00 |
| Mar 31, 2026 | 59,000.00 |
| Mar 31, 2026 | 59,000.00 |
| Dec 31, 2025 | 1.06 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 157,000.00 |
| Sep 30, 2025 | 157,000.00 |
| Jun 30, 2025 | 333,000.00 |
| Jun 30, 2025 | 333,000.00 |
| Mar 31, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | 699,000.00 |
| Dec 31, 2024 | 699,000.00 |
| Sep 30, 2024 | 1.94 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | 3.44 Mn |
| Mar 31, 2024 | 4.93 Mn |
| Mar 31, 2024 | 4.93 Mn |